Acalabrutinib, ibrutinib, CAR-T (CD 19) - Non Hodgkin's Lym...

Non Hodgkin's Lymphoma Friends

1,772 members799 posts

Acalabrutinib, ibrutinib, CAR-T (CD 19)

Mik_ profile image
Mik_
0 Replies

Is anybody was treated with CAR-T after failure of BTK blockers? I wonder if there any test to predict CAR-T efficacy and if you continue was taken BTK blocker during CAR-T treatment.

Written by
Mik_ profile image
Mik_
To view profiles and participate in discussions please or .
Read more about...

You may also like...

CAR-T Clinical Trial for CLL

aggressive follicular lymphoma) received an NIH CAR-T infusion (NCT02659943) on March 2, 2016 - she...

CAR-T Complete Remission Duration in Follicular Lymphoma

from Dr. Steven Schuster (one of the gurus in CAR-T) during today's Lymphoma Research Foundation...

Aggressive Follicular Lymphoma Now In NIH CAR-T Clinical Trial

Idelalisib/rituximab. After she progressed for the fourth time,in early 2016 she was accepted into...

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy

Key Points * CD19 CAR-T cell immunotherapy results in high CR rates in FL with or without...

Bispecific T-Cell Engagers (BiTEs) and Mantle Cell Lymphoma

v=SZlvJbCTJts&t=3s Potentially, more effective than CAR-T and less invasive. Regards, zentangle